Comprehensive Care for Kidney Tumors
Cincinnati Children's Hospital Medical Center is an international leader in caring for children with kidney tumors. Our integrated team of physicians and researchers is at the forefront of developing and testing more effective treatments for these tumors. Our work focuses on areas such as targeted radiation therapy and new drug therapies that prevent cancer cells from multiplying and spreading.
At Cincinnati Children’s, experienced specialists treat patients with newly diagnosed, advanced, rare and relapsed kidney cancers, including:
- Wilms’ tumor
- Renal cell carcinoma
- Rhabdoid tumors
- Clear cell sarcoma
- Renal angiomyolipoma
Leading-edge research
Cincinnati Children's is a major referral center for clinical care and research for the Children’s Oncology Group, the National Cancer Institute's new Pediatric Phase I Consortium and other national cancer research consortia. Many of our physicians serve in leadership positions for these organizations. We are the only site in Ohio, and one of just a few nationwide, to offer pediatric Phase I clinical trials of the newest cancer therapies. This level of engagement in research ensures that patients have access to the most innovative and effective cancer treatments available.
Cincinnati Children’s investigators have been leaders in characterizing, treating and developing novel therapies for pediatric renal cell carcinoma and other high-risk pediatric renal cancers. The Kidney Tumor Program’s director, James I. Geller, MD, plays a key role in developing next-generation kidney tumor treatments. His work benefits patients not only at Cincinnati Children’s, but also at other top medical centers around the world.
